Everything you need to know about treatment options for Type 1 and Type 2 Diabetes. Learn about the best medicines and the keep up with the latest research.
The FDA has issued a safety alert for the weight management medicine Belviq, Belviq XR (lorcaserin) due to a possible increased risk of cancer with
Eli Lilly today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin. The company plans to
French drugmaker, Sanofi SA announced on Tuesday that will stop pouring in money to research diabetes and cardiovascular (DCV). The news came from
Medically reviewed by Victor Nguyen, PharmD, MS on July 10, 2019 — Written by Helen Marshall, BPharm, MRPharmS. Republished with permission
Medically reviewed by Dena Westphalen, PharmD on July 30, 2019 — Written by Lindsay Slowiczek, PharmD. Republished with permission
The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s new drug, Rybelsus® (semaglutide) tablets for adults with Type 2
Novartis AG’s Sandoz unit, the maker of ranitidine, or Zantac, a popular heartburn medication announced today it would halt global
A Minnesota based health insurer, Medica, announced today it will expand its cap on the maximum amount members in North Dakota will pay for their
Less than half of the estimated 22 million people prescribed one or more diabetes medications are maintaining blood sugar levels within the
Medically reviewed by Zara Risoldi Cochrane, PharmD, MS, FASCP on April 24, 2019 — Written by Victor Nguyen, PharmD, MS. Republished with
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: